Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers

References

• LeeWThomasPSOxidative stress in COPD and its measurement through exhaled breath condensateClin Transl Sci20092215015520443881
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLCalero-AcuñaCLopez-RamirezCImplications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary diseaseBiomark Med201610210912226808692
   PubMed Web of Science ®Google Scholar
• HolguinFOxidative stress in airway diseasesAnn Am Thorac Soc201310SupplS150S15724313766
   PubMedGoogle Scholar
• BrownleeMAdvanced protein glycosylation in diabetes and agingAnnu Rev Med1995462232347598459
   PubMed Web of Science ®Google Scholar
• YamagishiSMatsuiTNakamuraKPossible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokersMed Hypotheses200871225926118448262
   PubMed Web of Science ®Google Scholar
• AhmadSKhanMSAkhterFGlycoxidation of biological macromolecules: a critical approach to halt the menace of glycationGlycobiology2014241197999024946787
   PubMed Web of Science ®Google Scholar
• CeramiCFoundsHNichollITobacco smoke is a source of toxic reactive glycation productsProc Natl Acad Sci USA1997942513915139209391127
   PubMed Web of Science ®Google Scholar
• BoschettoPCampoIStendardoMPlasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPDEur J Clin Invest201343656256923590548
   PubMed Web of Science ®Google Scholar
• HoonhorstSJLo Tam LoiATHartmanJEAdvanced glycation end products in the skin are enhanced in COPDMetabolism20146391149115625034386
   PubMed Web of Science ®Google Scholar
• WuLMaLNicholsonLFBlackPNAdvanced glycation end products and its receptor (RAGE) are increased in patients with COPDRespir Med2011105332933621112201
   PubMed Web of Science ®Google Scholar
• NeeperMSchmidtAMBrettJCloning and expression of a cell surface receptor for advanced glycosylation end products of proteinsJ Biol Chem19922672114998150041378843
   PubMed Web of Science ®Google Scholar
• SchmidtAMYanSDYanSFSternDMThe multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responsesJ Clin Invest2001108794995511581294
   PubMed Web of Science ®Google Scholar
• SukkarMBUllahMAGanWJRAGE: a new frontier in chronic airways diseaseBr J Pharmacol201216761161117622506507
   PubMed Web of Science ®Google Scholar
• YonchukJGSilvermanEKBowlerRPCirculating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lungAm J Respir Crit Care Med2015192778579226132989
   PubMed Web of Science ®Google Scholar
• YangSWangYMeiKTumor necrosis factor receptor 2 (TNFR2) interleukin-17 receptor D (IL-17RD) heteromerization reveals a novel mechanism for NF-κB activationJ Biol Chem2015290286187125378394
   PubMed Web of Science ®Google Scholar
• Ait-AliDTurquierVTanguyYTumor necrosis factor (TNF)-alpha persistently activates nuclear factor-kappaB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammationEndocrinology200814962840285218292192
   PubMed Web of Science ®Google Scholar
• BarnesPJCellular and molecular mechanisms of chronic obstructive pulmonary diseaseClin Chest Med2014351718624507838
   PubMed Web of Science ®Google Scholar
• MiniatiMMontiSBastaGCocciFFornaiEBottaiMSoluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control studyRespir Res2011123721450080
   PubMed Web of Science ®Google Scholar
• SmithDJYerkovichSTTowersMACarrollMLThomasRUphamJWReduced soluble receptor for advanced glycation end-products in COPDEur Respir J201137351652220595148
   PubMed Web of Science ®Google Scholar
• IwamotoHGaoJKoskelaJDifferences in plasma and sputum biomarkers between COPD and COPD-asthma overlapEur Respir J201443242142923794464
   PubMed Web of Science ®Google Scholar
• JiJvon SchéeleIBergströmJCompartment differences of inflammatory activity in chronic obstructive pulmonary diseaseRespir Res20141510425155252
   PubMed Web of Science ®Google Scholar
• D’hulstAIBrackeKRMaesTRole of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysemaEur Respir J200628110211216540505
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2017 Report: GOLD Executive SummaryEur Respir J2017493 pii:1700214
   Web of Science ®Google Scholar
• Standardization of spirometry – 1987 updateStatement of the American Thoracic SocietyAm Rev Respir Dis19871365128512983674589
   PubMedGoogle Scholar
• PereiraCBarretoSSimõesJPereiraFGerstlerJNakataniJValores de referência para a espirometria em uma amostra da populaçäo brasileira adultaJ Bras Pneumol1992181022
   Google Scholar
• ReichertJAraújoAJGonçalvesCMSociedade Brasileira de Pneumologia e TisiologiaDiretrizes para cessação do tabagismo [Smoking cessation guidelines – 2008.]J Bras Pneumol20083410845880 Portuguese19009219
   PubMedGoogle Scholar
• MiddletonETMoriceAHBreath carbon monoxide as an indication of smoking habitChest2000117375876310713003
   PubMed Web of Science ®Google Scholar
• SantosUGannamSAbeJEstevesPFilhoMWakassaTEmprego da determinação de monóxido de carbono no ar exalado para a detecção do consumo de tabaco [Use of carbon monoxide in the exhaled air for the detection of tobacco consumption]J Bras Pneumol200127231236 Portuguese
   Google Scholar
• BorgEscala CR10 de BorgBorgGEscala de Borg para dor e esforço percebido [Borg’s Perceived Exertion and Pain Scales]1 edSão Paulo2000
   Google Scholar
• KyleUGBosaeusIDe LorenzoADComposition of the ESPEN Working GroupBioelectrical impedance analysis – part I: review of principles and methodsClin Nutr20042351226124315380917
   PubMed Web of Science ®Google Scholar
• ScholsAMBroekhuizenRWeling-ScheepersCAWoutersEFBody composition and mortality in chronic obstructive pulmonary diseaseAm J Clin Nutr2005821535916002800
   PubMed Web of Science ®Google Scholar
• VistoliGDe MaddisDCipakAZarkovicNCariniMAldiniGAdvanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formationFree Radic Res201347Suppl 132723767955
   PubMed Web of Science ®Google Scholar
• VernooyJHKüçükaycanMJacobsJALocal and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputumAm J Respir Crit Care Med200216691218122412403691
   PubMed Web of Science ®Google Scholar
• TartagliaLAGoeddelDVReynoldsCStimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptorJ Immunol19931519463746418409424
   PubMed Web of Science ®Google Scholar
• ChengDTKimDKCockayneDATESRA and ECLIPSE InvestigatorsSystemic soluble receptor for advanced glycation end-products is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013188894895723947473
   PubMed Web of Science ®Google Scholar
• CarolanBJHughesGMorrowJThe association of plasma biomarkers with computed tomography-assessed emphysema phenotypesRespir Res20141512725306249
   PubMed Web of Science ®Google Scholar
• AgustíAEdwardsLDRennardSIEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
   PubMed Web of Science ®Google Scholar
• SerapinasDNarbekovasAJuskeviciusJSakalauskasRSystemic inflammation in COPD in relation to smoking statusMultidiscip Respir Med20116421421922958407
   PubMed Web of Science ®Google Scholar
• TonstadSCowanJLC-reactive protein as a predictor of disease in smokers and former smokers: a reviewInt J Clin Pract200963111634164119732183
   PubMed Web of Science ®Google Scholar
• HeinGEKöhlerMOelznerPSteinGFrankeSThe advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritisRheumatol Int200526213714115580352
   PubMed Web of Science ®Google Scholar
• ChenYJSheuMLTsaiKSYangRSLiuSHAdvanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end productsPLoS One201386e6661123776688
   PubMed Web of Science ®Google Scholar
• SunyerJForastiereFPekkanenJInteraction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkersNicotine Tob Res200911111347135319828434
   PubMed Web of Science ®Google Scholar
• CaramLMAmaralRAFerrariRSerum vitamin A and inflammatory markers in individuals with and without chronic obstructive pulmonary diseaseMediators Inflamm2015201586208626339144
   PubMed Web of Science ®Google Scholar
• TanniSEPelegrinoNRAngeleliAYCorreaCGodoyISmoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patientsJ Inflamm (Lond)201072920534161
   PubMed Web of Science ®Google Scholar
• WoodruffPGBarrRGBleeckerESPIROMICS Research GroupClinical significance of symptoms in smokers with preserved pulmonary functionN Engl J Med2016374191811182127168432
   PubMed Web of Science ®Google Scholar